Century Therapeutics (IPSC) Treasury Shares (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Treasury Shares data on file, last reported at $7.2 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $7.2 million, up 53.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (up 53.77% YoY), and the FY2025 annual result was $5.6 million, up 22646.69% from the prior year.
• Treasury Shares advanced to $7.2 million in Q1 2026 per IPSC's latest filing, from $5.6 million in the prior quarter.
• Over five years, Treasury Shares peaked at $7.2 million in Q1 2026 and troughed at $24731.0 in Q1 2024.
• A 5-year average of $2.0 million and a median of $247780.0 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares tumbled 90.5% in 2023, then surged 22646.69% in 2025.
• A 5-year view of Treasury Shares shows it stood at $193031.0 in 2022, then plunged by 74.4% to $49416.0 in 2023, then slumped by 49.77% to $24821.0 in 2024, then surged by 22646.69% to $5.6 million in 2025, then advanced by 27.37% to $7.2 million in 2026.
• Business Quant data shows IPSC's Treasury Shares at $7.2 million in Q1 2026, $5.6 million in Q4 2025, and $6.6 million in Q3 2025.